These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17105431)

  • 41. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
    Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
    J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific Triazine Herbicides Induce Amyloid-β42 Production.
    Portelius E; Durieu E; Bodin M; Cam M; Pannee J; Leuxe C; Mabondzo A; Oumata N; Galons H; Lee JY; Chang YT; Stϋber K; Koch P; Fontaine G; Potier MC; Manousopoulou A; Garbis SD; Covaci A; Van Dam D; De Deyn P; Karg F; Flajolet M; Omori C; Hata S; Suzuki T; Blennow K; Zetterberg H; Meijer L
    J Alzheimers Dis; 2016 Oct; 54(4):1593-1605. PubMed ID: 27589520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
    Huang Y; Li T; Eatherton A; Mitchell WL; Rong N; Ye L; Yang XJ; Jin S; Ding Y; Zhang J; Li Y; Wu Y; Jin Y; Sang Y; Cheng Z; Browne ER; Harrison DC; Hussain I; Wan Z; Hall A; Lau LF; Matsuoka Y
    Neuropharmacology; 2013 Jul; 70():278-86. PubMed ID: 23485401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. γ-Secretase modulator in Alzheimer's disease: shifting the end.
    Xia W; Wong ST; Hanlon E; Morin P
    J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of notch-sparing gamma-secretase inhibitors.
    Augelli-Szafran CE; Wei HX; Lu D; Zhang J; Gu Y; Yang T; Osenkowski P; Ye W; Wolfe MS
    Curr Alzheimer Res; 2010 May; 7(3):207-9. PubMed ID: 20088802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans.
    Ling IF; Golde TE; Galasko DR; Koo EH
    Alzheimers Res Ther; 2015; 7(1):55. PubMed ID: 26244059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of new Presenilin-1 phosphosites: implication for γ-secretase activity and Aβ production.
    Matz A; Halamoda-Kenzaoui B; Hamelin R; Mosser S; Alattia JR; Dimitrov M; Moniatte M; Fraering PC
    J Neurochem; 2015 May; 133(3):409-21. PubMed ID: 25458374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.
    Zhou Y; Suram A; Venugopal C; Prakasam A; Lin S; Su Y; Li B; Paul SM; Sambamurti K
    FASEB J; 2008 Jan; 22(1):47-54. PubMed ID: 17666454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides.
    Siegel G; Gerber H; Koch P; Bruestle O; Fraering PC; Rajendran L
    Cell Rep; 2017 Jun; 19(10):1967-1976. PubMed ID: 28591569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42.
    Munter LM; Voigt P; Harmeier A; Kaden D; Gottschalk KE; Weise C; Pipkorn R; Schaefer M; Langosch D; Multhaup G
    EMBO J; 2007 Mar; 26(6):1702-12. PubMed ID: 17332749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.
    Teng L; Zhao J; Wang F; Ma L; Pei G
    Cell Res; 2010 Feb; 20(2):138-53. PubMed ID: 20066010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation.
    Takahashi Y; Hayashi I; Tominari Y; Rikimaru K; Morohashi Y; Kan T; Natsugari H; Fukuyama T; Tomita T; Iwatsubo T
    J Biol Chem; 2003 May; 278(20):18664-70. PubMed ID: 12637581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current status and perspectives on the development of therapeutic agents for Alzheimer's disease].
    Hirouchi M
    Nihon Yakurigaku Zasshi; 2004 Jun; 123(6):421-7. PubMed ID: 15170082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.